GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Changmao Biochemical Engineering Co Ltd (HKSE:00954) » Definitions » YoY EBITDA Growth

Changmao Biochemical Engineering Co (HKSE:00954) YoY EBITDA Growth

: -82.73% (As of Jun. 2023)
View and export this data going back to 2002. Start your Free Trial

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Changmao Biochemical Engineering Co's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was -82.73%.

Changmao Biochemical Engineering Co's EBITDA per Share for the six months ended in Jun. 2023 was HK$0.02.


Changmao Biochemical Engineering Co YoY EBITDA Growth Historical Data

The historical data trend for Changmao Biochemical Engineering Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changmao Biochemical Engineering Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.25 -45.89 138.39 -3.37 -140.70

Changmao Biochemical Engineering Co Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
YoY EBITDA Growth Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,971.43 11,100.00 -57.21 -82.73 -244.19

Changmao Biochemical Engineering Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Changmao Biochemical Engineering Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

YoY EBITDA Growth (A: Dec. 2022 )
=(EBITDA per Share (A: Dec. 2022 )-EBITDA per Share (A: Dec. 2021 ))/ | EBITDA per Share (A: Dec. 2021 ) |
=(0.258-0.267)/ | 0.267 |
=-3.37 %

Changmao Biochemical Engineering Co's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

YoY EBITDA Growth (Q: Jun. 2023 )
=(EBITDA per Share (Q: Jun. 2023 )-EBITDA per Share (Q: Jun. 2022 )) / | EBITDA per Share (Q: Jun. 2022 )) |
=(0.019-0.11)/ | 0.11 |
=-82.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Changmao Biochemical Engineering Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Changmao Biochemical Engineering Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Changmao Biochemical Engineering Co (HKSE:00954) Business Description

Traded in Other Exchanges
N/A
Address
No. 1228 Chang Jiang Bei Road, New North Zone, Jiangsu Province, Changzhou City, CHN, 213034
Changmao Biochemical Engineering Co Ltd is an organic acid producer in the PRC. It produces organic acids products for sale to the food additive, chemical, and pharmaceutical industries. Its products are organic acids and their derivatives with four carbons in their structures including fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, L(+)-tartaric acid, D(-)-tartaric acid, DL-tartaric acid, L-aspartic acid, and aspartame. These products are used as food additives or medical intermediaries. Its products are produced along vertical production chains. Its geographic locations include Mainland China, Europe includes Great Britain, Germany, Turkey, Spain, and Italy, Asia Pacific includes Hong Kong, Indonesia, Australia, India, Thailand and Japan, America, and Others.

Changmao Biochemical Engineering Co (HKSE:00954) Headlines

No Headlines